Surgical effects and complications of indocyanine green-assisted internal limiting membrane peeling for idiopathic macular hole

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 8, 2007, Pages 883-889

  Nagai, Norihiro ^a   Ishida, Susumu ^a   Shinoda, Kei ^a,b   Imamura, Yutaka ^a   Noda, Kousuke ^a   Inoue, Makoto ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Complications; Indocyanine green; Internal limiting membrane; Macular hole; Vitreous surgery

Indexed keywords

INDOCYANINE GREEN; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; CONTRAST; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PIGMENT EPITHELIUM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RETINA MACULA HOLE; RETINOSCHISIS; RETROSPECTIVE STUDY; VISUAL ACUITY; VISUAL FIELD DEFECT; VITRECTOMY;

AGED; COLORING AGENTS; EPIRETINAL MEMBRANE; FEMALE; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; STAINING AND LABELING; VISUAL ACUITY; VITRECTOMY;

EID: 36348954518     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.00973.x     Document Type: Article

References (34)

1. Abels C, Karrer S, Baumler W, Goetz AE, Landthaler M & Szeimies RM (1998): Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma. Br J Cancer 77: 1021-1024.
2. Ando F, Sasano K, Suzuki F & Ohba N (2004): Indocyanine green-assisted ILM peeling in macular hole surgery revisited. Am J Ophthalmol 138: 886-887.
3. Baumler W, Abels C, Karrer S, Weiss T, Messmann H, Landthaler M & Szeimies RM (1999): Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer 80: 360-363.
4. Blem RI, Huynh PD & Thall EH (2002): Altered uptake of infrared diode laser by retina after intravitreal indocyanine green dye and internal limiting membrane peeling. Am J Ophthalmol 134: 285-286.
5. Brazitikos PD, Androudi S, Tsinopoulos I, Papadopoulos NT, Balidis M & Georgiadis N (2004): Functional and anatomic results of macular hole surgery complicated by massive indocyanine green subretinal migration. Acta Ophthalmol Scand 82: 613-615.
6. Brooks HL (2000): Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 107: 1939-1949.
7. Da Mata AP, Burk SE, Riemann CD, Rosa RH Jr, Snyder ME, Petersen MR & Foster RE (2001): Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macula hole repair. Ophthalmology 108: 1187-1192.
8. Enaida H, Sakamoto H, Hisatomi T, Goto Y & Ishibashi T (2002): Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol 240: 209-213.
9. Engelbrecht NE, Freeman J, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr, Martin DF & Sippy BD (2002): Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane. Am J Ophthalmol 133: 89-94.
10. Fox IJ, Brooker LGS, Heseltine DW & Wood EH (1957): A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Proc Mayo Clin 32: 478-484.
11. Fox IJ & Pood EH (1960): Indocyanine green: physical and physiological properties. Proc Mayo Clin 35: 732-744.
12. Gandorfer A, Haritoglou C, Gandorfer A & Kampik A (2003): Retinal damage from indocyanine in experimental macular surgery. Invest Ophthalmol Vis Sci 44: 316-323.
13. Gandorfer A, Haritoglou C, Gass CA, Ulbig MW & Kampik A (2001): Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 132: 431-433.
14. Gass JDM (1988): Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 106: 629-639.
15. Jackson TL, Hillenkamp J, Knight BC, Zhang JJ, Thomas D, Stanford MR & Marshall J (2004): Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 45: 2778-2785.
16. Kadonosono K, Itoh N, Uchio E, Nakamura S & Ohno S (2000): Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 118: 1116-1118.
17. Kanda S, Uemura A, Yamashita T, Kita H, Yamakiri K & Sakamoto T (2004): Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol 122: 1447-1451.
18. Kelly NE & Wendel RT (1991): Vitreous surgery for idiopathic macular holes: Results of pilot study. Arch Ophthalmol 109: 654-659.
19. Kerrison JB, Haller JA, Elman M & Miller NR (1997): Visual field loss following vitreous surgery. Arch Ophthalmol 115: 434-435.
20. Kiilgaard JF, Nissen MH & la Cour M (2006): An isotonic preparation of 1 mg/ml indocyanine green is not toxic to hyperconfluent ARPE19 cells, even after prolonged exposure. Acta Ophthalmol Scand 84: 42-46.
21. Kwok AK, Lai TY, Yew DT & Li WW (2003): Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries. Am J Ophthalmol 136: 223-230.
22. Kwok AK, Li WW, Pang CP, Lai TY, Yam GH, Chan NR & Lam DS (2001): Indocyanine green staining and removal of internal limiting membrane in macula hole surgery: History and outcome. Am J Ophthalmol 132: 178-183.
23. Liggett PE, Skolik DS, Horio B, Saito Y, Alfaro V & Mieler W (1995): Human autologous serum for the treatment of full-thickness macular holes. Ophthalmology 102: 1071-1076.
24. Michels M, Lewis H, Abrams GW, Han DP, Mieler WF & Neitz J (1992): Macular phototoxicity caused by fibre optic endoillumination during pars plana vitrectomy. Br J Ophthalmol 114: 287-296.
25. Murata M, Shimizu M, Horiuchi S & Sato S (2005): The effect of indocyanine green on cultured retinal glial cells. Retina 25: 75-80.
26. Park DW, Sipperley JO, Sneed SR, Dugel PU & Jacobsen J (1999): Macular hole surgery with internal limiting membrane peeling and intravitreous air. Ophthalmology 106: 1392-1398.
27. Sippy BD, Engelbrecht NE, Hubbard GB et al. (2001): Indocyanine green effect on cultured human retinal pigment epithelial cells: Implications for macular hole surgery. Am J Ophthalmol 132: 433-435.
28. Thompson JT, Smiddy WE, Williams GA, Sjaarda RN, Flynn HW Jr, Margherio RR & Abrams GW (1998): Comparison of recombinant transforming growth factor-β-2 and placebo as an adjunctive agent for macula hole surgery. Ophthalmology 105: 700-706.
29. Uemoto R, Yamamoto S, Aoki T, Tsukahara I, Yamamoto T & Takeuchi S (2002): Macular configuration determined by optical coherence tomography after idiopathic macular hole surgery with or without internal limiting membrane peeling. Br J Ophthalmol 86: 1240-1242.
30. Van den Biesen PR, Berenschot T, Verdaasdonk RM & Van Norren D (2000): Endoillumination during vitrectomy and photo-toxicity. Br J Ophthalmol 84: 1372-1375.
31. Weinberger AW, Kirchhof B, Mazinani BE & Schrage NF (2001): Persistent indocyanine green (ICG) fluorescence 6 weeks after intraocular ICG administration for macular surgery. Graefes Arch Clin Exp Ophthalmol 239: 388-390.
32. Yam HF, Kwok AK, Chan KP, Lai TY, Chu KY, Lam DS & Pang CP (2003): Effect of indocyanine green and illumination on gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 44: 370-377.
33. Yamashita Y, Sakai T, Watanabe K, Maekawa T & Shirakusa T (1999): Dye-enhanced selective laser ablation for surgical mucosectomy. Surg Laparosc Endosc Percutan Tech 9: 387-391.
34. Yooh HS, Brooks HL Jr, Capone A Jr, Hernault NL & Grossniklaus HE (1996): Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol 122: 67-75.